ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+12.26%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$199M
AUM Growth
+$199M
(+15%)
Cap. Flow
+$26.5M
Cap. Flow
% of AUM
13.33%
Top 10 Holdings %
Top 10 Hldgs %
56.26%
Holding
73
New
28
Increased
16
Reduced
8
Closed
5
Top Buys
| 1 |
Iovance Biotherapeutics
IOVA
|
$5.93M |
| 2 |
IRIDEX
IRIX
|
$5.24M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$4.98M |
| 4 |
DERM
Dermira, Inc.
DERM
|
$4.97M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
$3.02M |
Top Sells
| 1 |
CYNA
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
|
$7.96M |
| 2 |
Amicus Therapeutics
FOLD
|
$7.31M |
| 3 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$5.52M |
| 4 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$4.51M |
| 5 |
Universal Display
OLED
|
$3.73M |
Sector Composition
| 1 | Healthcare | 76.8% |
| 2 | Technology | 1.76% |
| 3 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Iovance Biotherapeutics
IOVA
$807M
| $26.2M | 12.58% | 3,232,416 +732,416 | +29% | +$5.93M |
|
2
Veracyte
VCYT
$2.39B
| $16M | 7.71% | 3,187,607 +450,965 | +16% | +$2.27M |
|
|
3
IRIDEX
IRIX
$22.8M
| $15M | 7.19% | 1,011,871 +354,201 | +54% | +$5.24M |
|
|
NDRM
4
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $10.3M | 4.95% | 634,000 -192,799 | -23% | -$3.13M |
|
|
IMMU
5
DELISTED
Immunomedics Inc
IMMU
| $9.74M | 4.68% | 4,200,000 -1,326,172 | -24% | -$3.08M |
|
|
RRM
6
DELISTED
RR MEDIA LTD ORD SHS (ISR)
RRM
| $8M | 3.84% | 611,818 +3,500 | +0.6% | +$45.7K |
|
|
EVDY
7
DELISTED
Everyday Health, Inc.
EVDY
| $7.45M | 3.58% | 945,000 +120,500 | +15% | +$950K |
|
|
CASM
8
DELISTED
CAS Medical Systems, Inc.
CASM
| $6.44M | 3.1% | 3,500,602 +821,849 | +31% | +$1.51M |
|
|
9
Amicus Therapeutics
FOLD
$2.34B
| $6.34M | 3.05% | 1,161,545 -1,338,455 | -54% | -$7.31M |
|
10
Ascendis Pharma
ASND
$11.8B
| $6.27M | 3.01% | 472,800 -150,831 | -24% | -$2M |
|
11
PDS Biotechnology
PDSB
$57.8M
| $5.36M | 2.57% | 530,000 +144,900 | +38% | +$1.46M |
|
|
12
BioMarin Pharmaceuticals
BMRN
$11.2B
| $4.98M | 2.39% | +64,000 | New | +$4.98M |
|
|
DERM
13
DELISTED
Dermira, Inc.
DERM
| $4.97M | 2.39% | +170,000 | New | +$4.97M |
|
14
Akebia Therapeutics
AKBA
$833M
| $4.49M | 2.16% | 600,000 +213,692 | +55% | +$1.6M |
|
|
NBRV
15
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $4.19M | 2.01% | 558,771 +13,799 | +3% | +$103K |
|
|
OXFD
16
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $3.76M | 1.8% | 417,278 +109,234 | +35% | +$983K |
|
|
CEMP
17
DELISTED
Cempra, Inc.
CEMP
| $3.46M | 1.66% | 210,000 | – | – |
|
|
INNL
18
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
| $3.13M | 1.5% | 568,137 +190,372 | +50% | +$1.05M |
|
|
MDVN
19
DELISTED
MEDIVATION, INC.
MDVN
| $3.02M | 1.45% | +50,000 | New | +$3.02M |
|
20
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.79M | 1.34% | +85,999 | New | +$2.79M |
|
|
TSRO
21
DELISTED
TESARO, Inc.
TSRO
| $2.52M | 1.21% | +30,000 | New | +$2.52M |
|
22
Sarepta Therapeutics
SRPT
$1.78B
| $2.48M | 1.19% | +130,000 | New | +$2.48M |
|
23
Marvell Technology
MRVL
$54.2B
| $2.28M | 1.1% | +239,588 | New | +$2.28M |
|
24
Insulet
PODD
$23.9B
| $2.27M | 1.09% | +75,000 | New | +$2.27M |
|
25
Insmed
INSM
$28.8B
| $2.17M | 1.04% | +220,000 | New | +$2.17M |
|